Case report links feline chronic enteropathy to intestinal stenosis

Bottom line

Version 1

A new Frontiers in Veterinary Science case report describes two cats that developed fibrostenotic intestinal stenosis while being managed for chronic enteropathy, underscoring a complication that may be easy to miss during long-term medical treatment. In one case, a cat treated with prednisolone for suspected chronic inflammatory enteropathy for 14 months developed a focal jejunal stricture with severe proximal dilation and died 12 days after surgery. In the second case, surgery with a wide-margin resection relieved a proximal small intestinal obstruction, and the cat remained free of restenosis for 12 months while continuing prednisolone; histopathology, immunohistochemistry, and PCR for antigen receptor rearrangement supported low-grade intestinal T-cell lymphoma in that cat. The report was published October 12, 2026, by Jiho Choi and colleagues at Chungbuk National University. (frontiersin.org)

Why it matters: For veterinary professionals, the cases add a practical warning to chronic feline GI management: obstruction in a cat with chronic enteropathy may reflect fibrostenotic change, not just ongoing inflammation or motility issues. That matters because feline chronic enteropathy is common, especially in older cats, and distinguishing inflammatory disease from low-grade lymphoma is already difficult. Prior work has also linked intestinal fibrosis in cats with chronic inflammatory enteropathy to poorer remission odds and death due to disease, while hypoalbuminemia and hypocobalaminemia have been associated with fibrosis, both features highlighted in the fatal case here. (pmc.ncbi.nlm.nih.gov)

What to watch: Whether these cases prompt more aggressive imaging follow-up, earlier surgical referral in obstructive presentations, or more discussion around fibrosis-focused pathology workups in cats with chronic enteropathy. (frontiersin.org)

Key facts

Article type
Case report
Journal
Frontiers in Veterinary Science
Publication date
October 12, 2026
Authors
Jiho Choi and colleagues
Institution
Chungbuk National University
Species
Cats
Condition
Fibrostenotic intestinal stenosis associated with chronic enteropathy
Case 1 treatment and outcome
Prednisolone for 14 months, focal jejunal stricture, died 12 days after surgery
Case 2 treatment and outcome
Wide-margin resection, no restenosis for 12 months while continuing prednisolone

Version 2

A newly published case report in Frontiers in Veterinary Science puts a spotlight on a rare but clinically important complication of feline chronic enteropathy: fibrostenotic intestinal stenosis. The report details two cats that developed obstructive intestinal strictures during the course of chronic enteropathy management, with sharply different outcomes, one fatal after surgery and one successful after wide-margin resection. The paper was published October 12, 2026, by Jiho Choi and colleagues from Chungbuk National University. (frontiersin.org)

The backdrop here is a familiar one for small animal practice. Chronic enteropathy is a common syndrome in cats, particularly older cats, and its prevalence has risen over the past two decades. It also remains one of the more frustrating diagnostic categories in feline medicine because inflammatory enteropathy and low-grade intestinal T-cell lymphoma can overlap clinically, ultrasonographically, and even histologically. ACVIM’s consensus guidance emphasizes that ambiguity often remains even after extensive workup, which helps explain why many cats spend long periods in medical management before a structural complication becomes obvious. (pmc.ncbi.nlm.nih.gov)

In the new report, the first cat had received prednisolone for 14 months for suspected chronic inflammatory enteropathy before presenting with progressive vomiting. Ultrasound showed small intestinal thickening and a focal jejunal stricture with marked proximal dilation. Exploratory laparotomy confirmed the lesion, and histopathology showed submucosal fibroplasia with mild lymphoplasmacytic enteritis. That cat died on postoperative day 12. The second cat presented with proximal small intestinal obstruction, underwent wide-margin resection, and recovered without restenosis over the following 12 months while remaining on prednisolone. In that case, histopathology found mild intestinal wall fibrosis with mesenteric inflammation, while Masson’s trichrome staining demonstrated submucosal collagen bundles and ancillary testing supported low-grade intestinal T-cell lymphoma. (frontiersin.org)

That pathology detail is especially relevant because fibrosis can be underrecognized if clinicians and pathologists are focused mainly on inflammatory cell populations. Separate BSAVA-reported research found that additional stains improved identification of intestinal fibrosis compared with H&E alone, and that colonic fibrosis in cats with chronic inflammatory enteropathy correlated with lower odds of clinical remission and death due to disease. The same work linked fibrosis with clinical features including weight loss, diarrhea, hypoalbuminemia, and hypocobalaminemia, offering a useful frame for interpreting the signal in these new cases. (bsava.com)

Direct expert reaction to this specific paper was limited at the time of writing, but the broader field has already been moving toward a more nuanced view of feline chronic enteropathy. Consensus and review literature consistently note that chronic inflammation, fibrosis, and low-grade lymphoma can coexist or blur diagnostic boundaries. That makes the second case particularly noteworthy: the successful outcome came despite evidence supporting low-grade intestinal T-cell lymphoma, suggesting that mechanical disease control through adequate resection may be just as important as the final inflammatory-versus-neoplastic label in selected obstructive cases. That’s an inference from the case report rather than a proven management rule, but it is supported by the authors’ conclusion that lesion extent and resection strategy may influence prognosis. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinarians, this report is less about prevalence than pattern recognition. A cat being medically managed for chronic enteropathy that develops worsening vomiting, segmental dilation on ultrasound, or signs of focal obstruction may need clinicians to think beyond refractory inflammation and consider fibrostenotic stricture. It also reinforces the value of a fuller diagnostic workup, including cobalamin assessment, careful imaging review, and, when surgery is pursued, pathology techniques that can better characterize fibrosis and possible low-grade lymphoma. For pet parents, the message is that a cat whose GI disease seems chronic and familiar can still develop a surgically relevant complication. (frontiersin.org)

What to watch: The next question is whether more case accumulation, or retrospective series, will clarify how often fibrostenotic stenosis complicates feline chronic enteropathy, which cats are at highest risk, and whether wider-margin resection should be favored when obstruction is identified. For now, the paper mainly serves as an early clinical signal: long-term medical management does not rule out later structural disease. (frontiersin.org)

Like what you're reading?

The Feed delivers veterinary news every weekday.